195 related articles for article (PubMed ID: 12454652)
1. Better therapeutics through microarrays.
Gerhold DL; Jensen RV; Gullans SR
Nat Genet; 2002 Dec; 32 Suppl():547-51. PubMed ID: 12454652
[TBL] [Abstract][Full Text] [Related]
2. DNA microarrays in drug discovery and development.
Debouck C; Goodfellow PN
Nat Genet; 1999 Jan; 21(1 Suppl):48-50. PubMed ID: 9915501
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling in drug discovery and development.
Stratowa C; Wilgenbus KK
Curr Opin Mol Ther; 1999 Dec; 1(6):671-9. PubMed ID: 19629863
[TBL] [Abstract][Full Text] [Related]
4. DNA microarrays: vital statistics.
Tilstone C
Nature; 2003 Aug; 424(6949):610-2. PubMed ID: 12904757
[No Abstract] [Full Text] [Related]
5. DNA microarrays and pharmacogenomics.
Meloni R; Khalfallah O; Biguet NF
Pharmacol Res; 2004 Apr; 49(4):303-8. PubMed ID: 15202510
[TBL] [Abstract][Full Text] [Related]
6. Microarrays: spotlight on gene function and pharmacogenomics.
Nees M; Woodworth CD
Curr Cancer Drug Targets; 2001 Aug; 1(2):155-75. PubMed ID: 12188888
[TBL] [Abstract][Full Text] [Related]
7. Platform technologies for microarray analysis.
Freeman T
Brief Funct Genomic Proteomic; 2003 Apr; 2(1):4-6. PubMed ID: 15239938
[No Abstract] [Full Text] [Related]
8. Pharmacogenetics: Role of Single Nucleotide Polymorphisms.
Yucesan E; Ozten N
Methods Mol Biol; 2019; 2054():137-145. PubMed ID: 31482453
[TBL] [Abstract][Full Text] [Related]
9. DNA microarrays: an overview of technologies and applications to toxicology.
Zarbl H
Curr Protoc Toxicol; 2001; Chapter 1():Unit1.4. PubMed ID: 23045022
[TBL] [Abstract][Full Text] [Related]
10. The Use of DNA Microarrays to Investigate the Pharmacogenomics of Drug Response in Living Systems.
Villeneuve DJ; Parissenti AM
Curr Top Med Chem; 2004; 4(13):1327-1343. PubMed ID: 15379648
[TBL] [Abstract][Full Text] [Related]
11. Analysis of DNA microarray data.
Hackl H; Sanchez Cabo F; Sturn A; Wolkenhauer O; Trajanoski Z
Curr Top Med Chem; 2004; 4(13):1357-70. PubMed ID: 15379650
[TBL] [Abstract][Full Text] [Related]
12. Fundamentals of experimental design for cDNA microarrays.
Churchill GA
Nat Genet; 2002 Dec; 32 Suppl():490-5. PubMed ID: 12454643
[TBL] [Abstract][Full Text] [Related]
13. Selecting normalization genes for small diagnostic microarrays.
Jaeger J; Spang R
BMC Bioinformatics; 2006 Aug; 7():388. PubMed ID: 16925821
[TBL] [Abstract][Full Text] [Related]
14. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays.
Gerhold D; Lu M; Xu J; Austin C; Caskey CT; Rushmore T
Physiol Genomics; 2001 Apr; 5(4):161-70. PubMed ID: 11328961
[TBL] [Abstract][Full Text] [Related]
15. Molecular portraits and the family tree of cancer.
Chung CH; Bernard PS; Perou CM
Nat Genet; 2002 Dec; 32 Suppl():533-40. PubMed ID: 12454650
[TBL] [Abstract][Full Text] [Related]
16. Observing the living genome.
Ferea TL; Brown PO
Curr Opin Genet Dev; 1999 Dec; 9(6):715-22. PubMed ID: 10607618
[TBL] [Abstract][Full Text] [Related]
17. DNA expression analysis: serial analysis of gene expression, microarrays and kidney disease.
Hayden PS; El-Meanawy A; Schelling JR; Sedor JR
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):407-14. PubMed ID: 12815337
[TBL] [Abstract][Full Text] [Related]
18. Applications of microarrays to histopathology.
van de Rijn M; Gilks CB
Histopathology; 2004 Feb; 44(2):97-108. PubMed ID: 14764053
[TBL] [Abstract][Full Text] [Related]
19. Resource and hardware options for microarray-based experimentation.
Affara NA
Brief Funct Genomic Proteomic; 2003 Apr; 2(1):7-20. PubMed ID: 15239939
[TBL] [Abstract][Full Text] [Related]
20. Chipping away at the mystery of drug responses.
Rockett JC
Pharmacogenomics J; 2001; 1(3):161-3. PubMed ID: 11908748
[No Abstract] [Full Text] [Related]
[Next] [New Search]